Discussions on with India for ‘expedited approval’ of Covid-19 vaccine: Pfizer
NEW DELHI: Global Pharma major Pfizer is discussing with the Indian government an expedited approval pathway to make Pfizer-BioNTech vaccine...
NEW DELHI: Global Pharma major Pfizer is discussing with the Indian government an expedited approval pathway to make Pfizer-BioNTech vaccine...
NEW DELHI: Global pharma major Pfizer is sending its medicines worth USD 70 million (over Rs 510 crore), from its...
NEW DELHI: Drug major Natco Pharma on Monday said it has received emergency use approval for Baricitinib tablets, for the...
NEW DELHI: With its aim to vaccinate a maximum number of people to curb the Covid-19 menace, the Centre has...
NEW DELHI: The Bombay High Court here on Sunday asked the Narendra Modi government (Central government) to increase the supply...
NEW DELHI: In line with his direction of exploring innovative ways to ramp up supply and availability of oxygen, PM...
MUMBAI: Serum Institute of India (SII) CEO Adar Poonawalla has said he will return to India from London in a...
NEW DELHI: A total of 86,023 beneficiaries in the age group of 18-44 years received their first dose of COVID...
NEW DELHI: More than 78 lakh COVID-19 vaccine doses are still available with the states and Union Territories (UTs) which...
NEW DELHI: India on Saturday received the first consignment of 1.5 lakh doses of Sputnik V COVID-19 vaccine from Russia...